Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Grid.org
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Smallpox Project === The ''Smallpox Research Grid'' was a part of United Devices "Patriot Grid" initiative to fight biological terrorism. This project helped analyze potential drug candidates for a medical therapy in the fight against smallpox virus. It made use of the "LigandFit" software (that had already been used by phase 2 of the Cancer Research project), but with a specialized set of target molecules that targeted the [[smallpox]] virus.<ref>{{cite web|url=http://grid.org/projects/smallpox/about.htm|title=About The Smallpox Project|publisher=grid.org|accessdate=2006-08-20|archiveurl=https://web.archive.org/web/20070927132908/http://grid.org/projects/smallpox/about.htm|archivedate=2007-09-27}}</ref> The partners of the project included [[University of Oxford]], the [[University of Western Ontario]], [[Memorial Sloan–Kettering Cancer Center]], [[Essex University]], [[Evotec OAI]], [[Accelrys]], and [[IBM]].<ref>{{cite web|url=http://grid.org/projects/smallpox/participants.htm|title=Smallpox participants|publisher=grid.org|accessdate=2006-08-20|archiveurl=https://web.archive.org/web/20070927132857/http://grid.org/projects/smallpox/participants.htm|archivedate=2007-09-27}}</ref> The [[World Community Grid]] largely began because of the success of this project.{{Citation needed |date= November 2013}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)